⌘K
We are a manufacturer of hygiene products with a growing presence in the Indian market. Under our brand framework, we have developed Femiss, Womanica, ElderFit and Bloom Baby, each designed to address consumer needs across the hygiene care spectrum, from babies to young women and the elderly. While our core focus has been on sanitary napkins, we have progressively diversified our portfolio to include a broader range of female care and wellness products, with Femiss catering to the economic segment through affordable and reliable sanitary napkins, Womanica offering premium high-absorbency solut
Deterministic verdict 'Neutral': listing=54/Neutral, short=63/Neutral Positive, long=65/Neutral; overall=53.3; confidence=93.3/100 | computed financials: fin=78, growth=94, D/E=0.51 (70% math / 30% model) | market signals: alignment=90 (OFS 20.0%), anchor quality=45 (marquee 13.5%), GMP trend=stable, overhang=54 | demand profile: reservation weights QIB/NII/Ret 30%/21%/49%, QIB effective demand=0.30x, institutional contribution=17%, breadth=0.90 | unlocks: anchor unlock ~13.8% of issue at T+30d, ~13.8% at T+90d | rule: mixed signals -> Neutral. | Analyst notes: The 'Apply' verdict is based on the company's strong financial performance, including robust revenue and PAT growth, and excellent return ratios. The post-IPO valuation is also attractive. However, this is tempered by significant operational and dependency risks, litigation concerns, and a subdued market sentiment. The long-term potential is present, but investors must be aware of the inherent risks and the SME nature of the IPO.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB Shares Offered | 29,08,800 | 47.44% | |
| NII (HNI) Shares Offered | 8,73,600 | 14.25% | |
| Retail Shares Offered | 20,38,400 | 33.25% | |
| Market Maker Shares Offered | 3,10,400 | 5.06% |
| Investor | |||
|---|---|---|---|
| NECTA BLOOM VCC-NECTA BLOOM ONE | 3,20,000 | ₹2.82 Cr | 18.98% |
| MONEYWISE FINANCIAL SERVICES PVT.LTD. | 2,27,200 | ₹2 Cr | 13.47% |
| KRUSHNAM NEXUS CAPITAL TRUST-KRUSHNAM NEXUS CAPITAL SCHEME 1 | 2,27,200 | ₹2 Cr | 13.47% |
| KUBER INDIA OPPORTUNITIES FUND | 2,27,200 | ₹2 Cr | 13.47% |
| CRAFT EMERGING MARKET FUND PCC-CITADEL CAPITAL FUND | 2,27,200 | ₹2 Cr | 13.47% |
| SAINT CAPITAL FUND | 3,40,800 | ₹3 Cr | 20.21% |
| RAJASTHAN GLOBAL SECURITIES PVT.LTD. | 1,16,800 | ₹1.03 Cr | 6.93% |
Strong and consistent revenue and PAT growth over the last three fiscal years.
Excellent profitability and capital efficiency as reflected by high ROE (30.9%), ROCE (24.86%), and RoNW (26.91%).
Attractive post-IPO P/E valuation of 17.53x, which is reasonable for an SME in a growth sector.
Diversified product portfolio under multiple brands catering to a wide demographic in the hygiene sector.
Modern manufacturing facility and a dual-channel distribution strategy.
Established brand affinity and customer trust.
Moderate debt-to-equity ratio (0.51).
Successful diversification into new product categories, expansion of distribution network, effective management of supply chain dependencies, and strong brand building leading to market share gains.
Continued steady growth in existing product lines, stable raw material prices, and maintenance of current operational efficiencies.
Intensified competition, inability to manage supplier/contract manufacturer dependencies, adverse impact from litigation, or failure to adapt to changing consumer preferences leading to market share loss and margin compression.
The GMP is low/non-existent and subscription levels are moderate, particularly from QIBs. While the valuation is attractive, the market sentiment does not indicate strong listing gains. Some gains are possible given the attractive valuation, but not guaranteed.
The short-term outlook is influenced by the subdued market sentiment and the inherent risks associated with SME IPOs. While the company's financials are strong, the immediate post-listing performance might be volatile due to these factors.
The company operates in a growing hygiene products market, demonstrates strong revenue and profit growth, and has excellent return ratios. The diversified product portfolio and brand strength offer long-term potential. However, significant operational and dependency risks need careful monitoring for sustained long-term performance.
Final verdict: Neutral (confidence High).
Positive: Strong and consistent revenue and PAT growth over the last three fiscal years.
Concern: History of negative net cash flows from operating and investing activities in some past years.
Listing-gain vs long-term: Neutral / Neutral.
Concern: High operational risks due to revenue concentration in one product category and dependency on a single manufacturing facility and contract manufacturer.